As of May 24, 2025, Open Orphan PLC (ORPH.L) reports a EV/EBITDA of 24.26.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Open Orphan PLC's EV/EBITDA to Peers
To better understand Open Orphan PLC's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Open Orphan PLC (ORPH.L) | 24.26 |
| Pangaea Oncology SA (PANG.MC) | 73.35 |
| AddLife AB (ALIF B.ST) | 34.60 |
| Genovis AB (GENO.ST) | 27.69 |
| Ergomed PLC (ERGO.L) | 26.54 |
| Bachem Holding AG (BANB.SW) | 20.30 |
Compared to its competitors, Open Orphan PLC's EV/EBITDA is among the highest compared to peers, suggesting the market values the company at a premium, possibly due to growth expectations.